cenegermin; cenegermin-bkbj (Oxervate, Sentinel)

Indications

• treatment of neurotrophic keratitis
• investigative treatment of dry eyes, retinitis pigmentosa, & glaucoma

Dosage

• 0.02 mg/mL

Mechanism of action

• recombinant human nerve growth factor
  • peripherally selective agonist of the TrkA & LNGFR (p75NTR)

More general terms

• ophthalmic agent (eyedrops)